Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting

Por van de Schans, Saskia A.M., Janssen-Heijnen, Maryska L.G., Nijziel, Marten R., Steyerberg, Ewout W., van Spronsen, Dick Johan
Publicado em 2010

Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands

Por van de Schans, Saskia A.M., van Steenbergen, Liza N., Coebergh, Jan Willem W., Janssen-Heijnen, Maryska L.G., van Spronsen, Dick Johan
Publicado em 2014

Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer

Por van Waalwijk, Maren A., van de Schans, Saskia A. M., Haak, Harm R., Extermann, Martine, Dercksen, Wouter M. W., Janssen-Heijnen, Maryska L. G.
Publicado no J Comorb (2011)

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989–2010

Por Issa, Djamila E., van de Schans, Saskia A.M., Chamuleau, Martine E.D., Karim-Kos, Henrike E., Wondergem, Marielle, Huijgens, Peter C., Coebergh, Jan Willem W., Zweegman, Sonja, Visser, Otto
Publicado no Haematologica (2015)

Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?

Por Stienen, J. J. C., Ottevanger, P. B., Wennekes, L., van de Schans, S. A. M., Dekker, H. M., van der Maazen, R. W. M., van Krieken, J. H. J. M., Blijlevens, N. M. A., Hermens, R. P. M. G.
Publicado no Ann Hematol (2015)

Variation in guideline adherence in non-Hodgkin’s lymphoma care: impact of patient and hospital characteristics

Por Stienen, Jozette J.C., Hermens, Rosella P.M.G., Wennekes, Lianne, van de Schans, Saskia A.M., van der Maazen, Richard W.M., Dekker, Helena M., Liefers, Janine, van Krieken, Johan H.J.M., Blijlevens, Nicole M.A., Ottevanger, Petronella B.
Publicado no BMC Cancer (2015)